aminoimidazole carboxamide has been researched along with Leukemia, Myeloid, Acute in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batinic, D; Batinic, J; Bedalov, A; Dembitz, V; Dubravcic, K; Kodvanj, I; Lalic, H; Tomic, B; Visnjic, D | 1 |
| Dembitz, V; Lalic, H; Visnjic, D | 1 |
| Chen, L; Han, F; Qu, H; Ren, L; Yan, H; Yang, S | 1 |
| Banfic, H; Dembitz, V; Lalic, H; Lukinovic-Skudar, V; Visnjic, D | 1 |
| Altman, MD; Bachman, E; Bouthillette, M; Chan, G; Childers, KK; Haidle, AM; Marshall, CG; Mathur, A; Mo, JR; Rosenstein, C; Rush, T; Tempest, P; Xu, L; Young, JR; Zabierek, AA | 1 |
1 review(s) available for aminoimidazole carboxamide and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Clinical Trials as Topic; Humans; Leukemia, Myeloid, Acute; Metformin; Ribonucleosides; RNA, Small Interfering; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2019 |
4 other study(ies) available for aminoimidazole carboxamide and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts.
Topics: Aminoimidazole Carboxamide; Biomarkers, Tumor; Blast Crisis; Bone Marrow; Case-Control Studies; Cell Differentiation; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Ribonucleosides; RNA-Seq; Tumor Cells, Cultured | 2020 |
Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; HL-60 Cells; Humans; Hypoglycemic Agents; Leukemia, Myeloid, Acute; Oxides; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Ribonucleotides; Signal Transduction; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2013 |
5-Aminoimidazole-4-carboxamide ribonucleoside induces differentiation of acute myeloid leukemia cells.
Topics: Aminoimidazole Carboxamide; Apoptosis; Cell Differentiation; Cell Line, Tumor; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Ribonucleotides; Signal Transduction; Tumor Cells, Cultured | 2014 |
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms.
Topics: Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Disease Models, Animal; Enzyme Activation; Humans; Janus Kinase 2; Leukemia, Myeloid, Acute; Microsomes; Models, Biological; Molecular Structure; Protein Kinase Inhibitors; Rats; Thiophenes | 2014 |